Passive Smoking, Excretion of Metabolites, and Health Effects: Results of the Leipzig's Allergy Risk Study (LARS)

Archives of Environmental Health

Volumn 57, Issue 4, 2002, Pages 326-331

  Rolle Kampczyk, Ulrike E ^a   Rehwagen, Martina ^a   Diez, Ulrike ^a   Richter, Matthias ^a   Herbarth, Olf ^a   Borte, Michael ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Allergy; Children; Lars; Leipzig's allergy risk study; Metabolites; Passive smoking; S benzylmercapturic acid; Urine; Vocs

Indexed keywords

VOLATILE ORGANIC COMPOUND;

AIR POLLUTION; ALLERGIC REACTION; ALLERGY; AMBIENT AIR; ARTICLE; ATOPY; CONTAMINATION; DATA ANALYSIS; ECZEMA; FEMALE; HUMAN; INDUSTRIALIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; PASSIVE SMOKING; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0036664933     PISSN: 00039896     EISSN: None     Source Type: Journal    
DOI: 10.1080/00039890209601416     Document Type: Article

References (39)

1. ISAAC. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351:1225.
2. Schäfer T, Ring J. Epidemiology of allergic diseases. Allergy 1997; 52(38): 14-22.
3. Seifert B, Ullrich D, Mailahn W, et al. Flüchtige organische Verbindungen in der Inneraumluft Bundesgesundhbl. [Volatile organic compounds in indoor air.] Fed Health J 1986; 29(12): 417-24.
4. Wallace L, Pellizzari E, Hartwell TD, et al. Exposure to benzene and other volatile compounds from active and passive smoking. Arch Environ Health 1987; 42(5):272-79.
5. Wieslander G, Norbäck D, Björnsson E, et al. Asthma in the indoor environment: the significance of emission of formaldehyde and volatile organic compounds from new painted indoor surfaces. Int Arch Environ Health 1997; 69:115-24.
6. Norbäck D, Björnsson E, Janson C, et al. Asthmatic symptoms and volatile compounds formaldehyde and CO? Occup Environ Med 1995;52:388-95.
7. Lastboom L, Boman A, Camner P, et al. Does airway responsiveness increase after skin sensitisation to 3-carene: a study in isolated guinea pig lungs. Toxicology 1998; 125:59-66.
8. Alarie Y, Nielsen GD, Andonian-Haftvan J, et al. Physiochemical properties of nonreactive volatile organic chemicals to estimate RD50: alternatives to animals studies. Toxicol Appl Pharmacol 1995; 134:92-99.
9. Alarie Y, Schaper M, Nielsen GD, et al. Estimating the sensory irritating potency of airborne nonreactive volatile organic chemicals and their mixtures. SAR QSAR Environ Res 1996; 5:151-65.
10. Alarie Y, Schaper M, Nielsen GD, et al. Structure activity relationships of volatile organic chemicals as sensory irritants. Arch Toxicol 1998; 72:125-40.
11. Molhave L, Bach, B, Pedersen OF. Human reactions to low concentrations of volatile organic compounds. Environ Int 1986; 12:167-75.
12. Korpi A, Kasanen JP. Sensory irritating potency of some microbial volatile organic compounds and a mixture of five MVOCs. Arch Environ Health 1999;54:347-52.
13. International Agency for Research on Cancer (IARC) Monographs. Tobacco Smoking. Lyon, France: IARC, 1986; 38:1-421.
14. Hajimiragha H, Ewers U, Brockhaus A, et al. Levels of benzene and other volatile aromatic compounds in the blood of non-smokers and smokers. Int Arch Occup Environ Health 1989; 61:513-18.
15. Diez U, Kroeßner T, Rehwagen M, et al. Effects of indoor painting and smoking on airway symptoms in atopy risk children in the first year of life results of the LARS-study. Int J Hyg Environ Health 2000; 203:23-28.
16. Tager IB, Hanrahan JP, Tosteson TD, et al. Lung function pre-and postnatal smoke exposure and wheezing in the first year of life. Am Rev Respir Dis 1993; 147:811-17.
17. Etzel RA. Indoor air pollution and childhood asthma: effective environmental interventions. Environ Health Perspect 1995; 103(6):55-58.
18. Skolnick ET, Vonvolakis MA, Buck A, et al. Exposure to environmental tobacco smoke and the risk of adverse respiratory events in children receiving general anesthesia. Anethesiology 1998; 88:1141-42.
19. Knight JM, Eliopoulos C, Klein J, et al. Pharmacokinetic predisposition to nicotine from environmental tobacco smoke: a risk factor for pediatric asthma. J Asthma 1998; 35(1):113-17.
20. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996; 18(2):188-204.
21. Kulig M, Luck W, Lau S, et al. Effect of pre-and postnatal tobacco smoke exposure on specific sensitization to food and inhalant allergens during the first 3 years of life. Multicenter Allergy Study Group, Germany. Allergy 1999; 54(3):220-28.
22. Joad JP. Smoking and pediatric respiratory health. Clin Chest Med 2000; 21(1):37-46.
23. Rolle-Kampczyk U, Herbarth O, Rehwagen M. Noninvasive diagnostic methods in environmental medicine-biomonitoring of specific exposure dependent metabolites. J Environ Med 1999; 1:65-70.
24. Ong CN, Lee LB. Determination of benzene and its metabolites application in biological monitoring of environmental and occupational exposure to benzene. J Chromatogr B Analyt Technol Biomed Life Sci 1994; 660:1-22.
25. Greim H, Csanady G, Filser JG, et al. Biomarkers as tools in human health risk assessment. Clin Chem 1995; 12:1804-08.
26. Ikeda M. Exposure to complex mixtures: implications for biological monitoring. Toxicol Lett 1995; 77:85-91.
27. Lowry LK. Role of biomarkers of exposure in the assessment of health risks. Toxicol Lett 1995; 77:31-38.
28. van Sittert NJ, Booggaard PJ, Beulink GDJ. Application of the urinary S-phenylmercapturic acid test as a biomarker for low levels of exposure to benzene in industry. Br J Ind Med 1993; 50: 460-69.
29. Takahashi S, Matsubara K, Hasegawa M, et al. Detection and measurement of S-benzyl-N-acetylcysteine in urine of toluene sniffers using capillary gas chromatography. Arch Toxicol 1993; 67:647-50.
30. Takahashi S, Kagawa M, Shiwaku K, et al. Determination of S-benzyl-/V-acetyl-L/ysteine by gas chromatography/mass spectrometry as a new marker of toluene exposure. J Anal Toxicol 1994; 18:78-80.
31. Angerer J, Schildbach M, Krämer A. S-p-toluylmercapturic acid in the urine of workers exposed to toluene: a new biomarker for toluene exposure. Arch Toxicol 1998; 72:119-23.
32. Boogaard PJ, van Sittert NJ. Biological monitoring of exposure to benzene: a comparison between S-phenylmercapturic acid, trans, frans-muconic acid, and phenol. Occup Environ Med 1995; 52:611-20.
33. Einig D, Dunemann L, Dehnen W. Sensitive gas chromatographic method for determination of mercapturic acids in human urine. J Chromatogr B Analyt Technol Biomed Life Sci 1996; 687: 379-85.
34. Norström A, Andersson B, Aringer L, et al. Determination of specific mercapturic acids in human urine after experimental exposure to toluene or o-xylene. IARC Sci Publ 1988; 89: 232-34.
35. Rolle-Kampczyk U, Rehwagen M, Herbarth O. Is the internal burden in human beings reflected by air pollution measurements? Air Pollution 1999; 7:447-55.
36. Margolis PA, Keyes LL, Greenberg RA, et al. Urinary cotinine and parent history (questionnaire) as indicators of passive smoking and predictors of lower respiratory illness in infants. Pediatr Pul-monol 1997; 23 (6):417-23.
37. Wahn U. Environmental factors facilitating allergic sensitization and atopic manifestation in early childhood. Nutr Res 1998; 18:1363-71.
38. Davis RA, Stiles MF, de Bethizy et al. Dietary nicotine: a source of urinary cotinine. Food Chem Toxicol 1991; 29:821-27.
39. Haufroid V, Hotz P, Carbonelle P, et al. Relationship between smoking habits, smoking-associated hematological changes and urinary benzene metabolites. J Toxicol Environ Health 1997; 52: 1-17.